The Comparative Study of Nanoparticle Carriers for Targeted Drug Delivery
DOI:
https://doi.org/10.47611/jsrhs.v13i3.7170Keywords:
Liposomes, dendrimers, Polymeric Nanoparticles, CancerAbstract
This study compares and contrasts different types of nanoparticle carriers, such as liposomes, dendrimers, and polymeric nanoparticles. Its primary focus is on how well, specifically, and biocompatible, these nanoparticles work in focused drug delivery systems. This study uses advanced testing methods to determine how precisely these nanoparticles can target and reach specific cells or tissues. This could lead to better treatment results and fewer side effects. The research discovered that these particles carry medicine in different ways and that their size and the way their surfaces are made are significant to how well they work. Also, tests that check nanoparticles' biocompatibility show that their chemical and physical features are significant in how they interact with living things. This study helps us understand how nanoparticle medicine delivers drugs mechanically and lays the groundwork for making nanotherapeutics that work better and are safer. The results show that nanoparticle transporters could be used in specific treatments. This would lead to more personalized and precise medical care.
Downloads
References or Bibliography
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., ... & Barnholtz-Sloan, J. S. (2020). CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro-Oncology, 22(12), iv1-iv96.
Gutkin, A., Cohen, Z. R., & Peer, D. (2016). Harnessing nanomedicine for therapeutic intervention in glioblastoma. Expert Opinion on Drug Delivery, 13(11), 1573-1582. https://doi.org/10.1080/17425247.2016.1200557
Kim, S. S., Harford, J. B., Pirollo, K. F., & Chang, E. H. (2015). Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors, including cancer stem cells: The promise of nanomedicine. Biochemical and Biophysical Research Communications, 468(3), 485-489. https://doi.org/10.1016/j.bbrc.2015.06.137
Explore more about Nanotechnology - NIBIB
Explore More Research | National Institute of Biomedical Imaging and Bioengineering (nih.gov)
Pourgholi, F., Hajivalili, M., Farhad, J. N., Kafil, H. S., & Yousefi, M. (2016). Nanoparticles: Novel vehicles in treatment of Glioblastoma. Biomedicine & Pharmacotherapy, 77, 98-107. https://doi.org/10.1016/j.biopha.2015.12.014
National Health Expenditure Projections 2019-2028" by Centers for Medicare & Medicaid Services (CMS)
Forecast Summary 2019-2028 FINAL_0.pdf (cms.gov)
Jena, L., McErlean, E., & McCarthy, H. (2020). Delivery across the blood-brain barrier: Nanomedicine for glioblastoma multiforme. Drug Delivery and Translational Research, 10(2), 304-318. https://doi.org/10.1007/s13346-019-00679-2
Therapeutic Potential of Targeted Nanoparticles and Perspective on Nanotherapies
Therapeutic Potential of Targeted Nanoparticles and Perspective on Nanotherapies | ACS Medicinal Chemistry Letters
Published
How to Cite
Issue
Section
Copyright (c) 2024 Rhea Thurumella; Dr.Kristina Lilova, Virgal Torremoch, Jothsna Kethar

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.